Life Science – Regulation Gives Way To Innovation
Over the decade of the 2000s it became increasingly clear that structural issues made investing in biotech companies a high-risk, low return game. The clinical trial process lasted a decade, and cost...
✴️Applications are open for @Bridge_GLBL!
Women emerging managers: Learn more about the programming you can access,... selection criteria & process, as well as the🔗to apply here: https://bridgefundingglobal.com/membership
Honored to have @SapphirePrtnrs on this year's cohort selection committee!
🎧@AcquiredFM has the latest must-listen podcast
@altcap Partner @MeghanKReynolds (fmr @tpg) talks strategic capital... formation w @gilbert & @djrosent: Why it's much more than IR + #fundraising; how/why it's going to change dramatically in the next decade
It's not an easy time to raise a #VC fund for many managers right now. Great advice 💎 on how to from @HarryStebbings ... on this podcast https://spoti.fi/3IRkBDK
- your fund size is your strategy
- navigating the world of LPs
- getting the LP fly wheel going
Latest edition of @weekendfund's Signature Block is out & features @SapphirePrtnrs' @Beezer232 who shares how ... institutional #LPs evaluate funds & offers tips to emerging managers on standing out.
Check out the full LP AMA👇
🙏@rrhoover & @vedikaja_in